Pivotal Business Managers LLP has bought 8.25 lakh equity shares of Shilpa Medicare at Rs 292.91 per equity share on the BSE on March 20, 2020. On other hand, Pivotal Enterprises has offloaded 8.25 lakh equity shares of the company at Rs 292.86 per equity share on the BSE, on the same day.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
